The Mean Platelet Volume and Atherogenic Index of Plasma in Nondipper Normotensive Individuals Compared to Dippers

REFERENCES

• Yarlıoglues M, Kaya MG, Ardic I, . Relationship between mean platelet volume levels and subclinical target organ damage in newly diagnosed hypertensive patients. Blood Press 2011; 20(2):92–97.
   PubMed Web of Science ®Google Scholar
• Soylu A, Güleç H, Alihanoğlu YI, Sönmez O, Ayhan SS, Gök H. The effect of nondipper blood pressure pattern on target organ damage in patients with metabolic syndrome. Arch Turk Soc Cardiol 2009; 37(7):454–460.
   Google Scholar
• Garcia-Ortiz L, Gomez-Marcos MA, Martin-Moreiras J, . Pulse pressure and nocturnal fall in blood pressure are predictors of vascular, cardiac and renal target organ damage in hypertensive patients (LOD-RISK study). Blood Press Monit 2009; 14(4):145–151.
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Akiguchi I, Oiwa K, Hayashi M, Ohara T, Ozasa K. The relationship between 24-hour blood pressure readings, subcortical ischemic lesions and vascular dementia. Cerebrovasc Dis 2005; 19(5):302–308.
   PubMed Web of Science ®Google Scholar
• Tsioufis C, Antoniadis D, Stefanadis C, . Relationships between new risk factors and circadian blood pressure variation in untreated subjects with essential hypertension. Am J Hypertens 2002; 15(7):600–604.
   PubMed Web of Science ®Google Scholar
• Hekimsoy Z, Payzin B, Ornek T, Kandogan G. Mean platelet volume in Type 2 diabetic patients. J Diabetes Complicat 2004; 18(3):173–176.
   PubMed Web of Science ®Google Scholar
• Park Y, Schoene N, Haris W. Mean platelet volume as an indicator of platelet activation: methodological issues. Platelets 2002; 13(5–6):301–306.
   PubMed Web of Science ®Google Scholar
• Lamarche B, Lemieux I, Despres JP. The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, pathophysiology and therapeutic aspects. Diabetes Metab 1999; 25:199–211.
   PubMed Web of Science ®Google Scholar
• Vakkilainen J, Steiner G, Ansquer JC, . Relationships between low-density lipoprotein particle size, plasma lipoproteins, and progression of coronary artery disease: the Diabetes Atherosclerosis Intervention Study (DAIS). Circulation 2003; 107:1733–1737.
   PubMed Web of Science ®Google Scholar
• Carmena R, Duriez P, Fruchart JC. Atherogenic lipoprotein particles in atherosclerosis. Circulation 2004; 109:2–7.
   PubMed Web of Science ®Google Scholar
• Dobiasova M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER (HDL)). Clin Biochem 2001; 34:583–588.
   PubMed Web of Science ®Google Scholar
• Koren E, Corder C, Mueller G, . Triglyceride enriched lipoprotein particles correlate with the severity of coronary artery disease. Atherosclerosis 1996; 122:105–115.
   PubMed Web of Science ®Google Scholar
• Drexel H, Aman FW, Rentsch K, . Relation of the level of high-density lipoprotein subfractions to the presence and extent of coronary artery disease. Am J Cardiol 1992; 70:436–440.
   PubMed Web of Science ®Google Scholar
• Frohlich J, Dobiáová M, Lear S, Lee K. The role of risk factors in the development of atherosclerosis. Crit Rev Clin Lab Sci 2001; 38:401–440.
   PubMed Web of Science ®Google Scholar
• Nagahama K, Iseki K, Inoue T, Touma T, Ikemiya Y, Takishita S. Hyperuricemia and cardiovascular risk factor clustering in a screened cohort in Okinawa, Japan. Hypertens Res 2004; 27:227–233.
   PubMed Web of Science ®Google Scholar
• Endler G, Klimesch A, Sunder-Plassmann H, . Mean platelet volume is an independent risk factor for myocardial infarction but nor for coronary artery disease. Br J Haematol 2002; 117:399–404.
   PubMed Web of Science ®Google Scholar
• Ohkubo T, Hozawa A, Yamaguchi J, . Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens 2002; 20:2183–2189.
   PubMed Web of Science ®Google Scholar
• Yazıcı M, Demircan S, Durna K, Yaşar E, Şahin M. The incidence of nondipping state in normotensive patients with coronary slow flow and its relationship with prognosis. Arch Turk Soc Cardiol 2005; 33(6):319–325.
   Google Scholar
• Libby P. Coronary artery injury and the biology of atherosclerosis: inflammation, thrombosis, and stabilization. Am J Cardiol 2000; 86(8):3–8.
   Google Scholar
• Senaran H, İleri M, Altinbas A, . Thrombopoietin and mean platelet volume in coronary artery disease. Clin Cardiol 2001; 24(5):405–408.
   PubMed Web of Science ®Google Scholar
• Grove EL, Orntoft TF, Lassen JF, Jensen HK, Kristensen SD. The platelet polymorphism PlA2 is a genetic risk factor for myocardial infarction. J Intern Med 2004; 255(6):637–644.
   PubMed Web of Science ®Google Scholar
• Norgaz T, Hobikoglu G, Aksu H, . The relationship between preprocedural platelet size and subsequent in-stent restenosis. Acta Cardiol 2004; 59(4):391–395.
   PubMed Web of Science ®Google Scholar
• Coban E, Yazicioğlu G, Berkant Avci A, Akcit F. The mean platelet volume in patients with essential and white coat hypertension. Platelets 2005; 16(7):435–438.
   PubMed Web of Science ®Google Scholar
• Nadar SK, Caine GJ, Blann AD, Lip GY. Platelet adhesion in hypertension: application of a novel assay of platelet adhesion. Ann Med 2005; 37(1):55–60.
   PubMed Web of Science ®Google Scholar
• Inanc T, Kaya MG, Yarlioglues M, . The mean platelet volume in patients with non-dipper hypertension compared to dippers and normotensives. Blood Press 2010; 19(2):81–85.
   PubMed Web of Science ®Google Scholar
• Nadar SK, Lip GY. The prothrombotic state in hypertension and the effects of antihypertensive treatment. Curr Pharm Des 2003; 9(21):1715–1732.
   PubMed Web of Science ®Google Scholar
• Blann AD, Nadar S, Lip GY. Pharmacological modulation of platelet function in hypertension. Hypertension 2003; 42(1):1–7.
   PubMed Web of Science ®Google Scholar
• Ordu S, Ozhan H, Caglar O, . Mean platelet volume in patients with dipper and non-dipper hypertension. Blood Press 2010; 19(1):26–30.
   PubMed Web of Science ®Google Scholar
• Williams PT, Superko HR, Haskell WL, . Smallest LDL particles are most strongly related to coronary disease progression in men. Arterioscler Thromb Vasc Biol 2003; 23:314–321.
   PubMed Web of Science ®Google Scholar
• Rosenson RS, Otvos JD, Freedman DS. Relations of lipoprotein subclass levels and low-density lipoprotein size to progression on coronary artery disease in the Provastatin Limitation of Atherosclerosis in the Coronary Arteries (PLAC-I) trial. Am J Cardiol 2002; 90:89–94.
   PubMed Web of Science ®Google Scholar
• Mohan V, Deepa R, Velmurugan K, Gokulakrishnan K. Association of small dense LDL with coronary artery disease and diabetes in urban Asian Indians—The Chennai Urban Epidemiology Study (CURES 8). J Assoc Physcians India 2005; 53:95–100.
   PubMedGoogle Scholar
• Packard CJ. Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein. Biochem Soc Trans 2003; 31(5):1066–1069.
   PubMedGoogle Scholar
• Dobiasova M, Frohlich J. Fractional esterification rate of cholesterol and ratio of triglycerides to HDL-cholesterol are powerful predictors of positive findings on coronary angiography. Clin Chem 2003; 49:1873–1880.
   PubMed Web of Science ®Google Scholar
• Maruyama C, Imamura K, Teramoto T. Assessment of LDL particle size by triglyceride/HDL-cholesterol ratio in non-diabetic, healthy subjects without prominent hyperlipidemia. J Atheroscler Thromb 2003; 10:186–191.
   PubMedGoogle Scholar